Correlation between MASCC score and the evolution of febrile neutropenia in patients with solid tumors: a retrospective study

Key Points

• Febrile neutropenia prediction is significantly linked to the MASCC score, highlighting its clinical relevance.
• The study reports that higher MASCC scores correlate with better clinical outcomes in 120 patients with solid tumors.
• Retrospective analysis evaluates patient data over two years to assess febrile neutropenia risks.
• Findings suggest using the MASCC score could enhance patient management strategies within oncology.